This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Qpex Biopharma, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Thomas Linder: Innovator in Antimicrobial Compounds
Introduction
Thomas Linder is a notable inventor based in Linz, Austria. He has made significant contributions to the field of antimicrobial compounds, particularly through his innovative work on boronic acid derivatives. His research focuses on the synthesis, polymorphic forms, and therapeutic uses of these compounds.
Latest Patents
Linder holds a patent for "Boronic acid derivatives and synthesis, polymorphic forms, and therapeutic uses thereof." This patent discloses antimicrobial compounds, polymorphic forms, and pharmaceutical compositions. It also details methods of use and preparation, with some embodiments relating to boronic acid derivatives as therapeutic agents, such as β-lactamase inhibitors (BLIs). He has 1 patent to his name.
Career Highlights
Thomas Linder is currently associated with Qpex Biopharma, Inc., where he continues to advance his research in the pharmaceutical field. His work is pivotal in developing new therapeutic agents that can combat bacterial resistance.
Collaborations
Linder collaborates with esteemed colleagues, including Matthew M Bio and Laurent Lefort, to further enhance the impact of his research in antimicrobial therapies.
Conclusion
Thomas Linder's innovative work in the field of antimicrobial compounds showcases his dedication to advancing medical science. His contributions are vital in the ongoing battle against antibiotic resistance.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile